Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Nov;93(11):1207–1212. doi: 10.1111/j.1349-7006.2002.tb01225.x

Fuzzy Neural Network Applied to Gene Expression Profiling for Predicting the Prognosis of Diffuse Large B‐cell Lymphoma

Tatsuya Ando 1, Miyuki Suguro 2, Taizo Hanai 1,†, Takeshi Kobayashi 1, Hiroyuki Honda 1,✉, Masao Seto 2
PMCID: PMC5926895  PMID: 12460461

Abstract

Diffuse large B‐cell lymphoma (DLBCL) is the largest category of aggressive lymphomas. Less than 50% of patients can be cured by combination chemotherapy. Microarray technologies have recently shown that the response to chemotherapy reflects the molecular heterogeneity in DLBCL. On the basis of published microarray data, we attempted to develop a long‐overdue method for the precise and simple prediction of survival of DLBCL patients. We developed a fuzzy neural network (FNN) model to analyze gene expression profiling data for DLBCL. From data on 5857 genes, this model identified four genes (CD10, AA807551, AA805611 and IRF‐4) that could be used to predict prognosis with 93% accuracy. FNNs are powerful tools for extracting significant biological markers affecting prognosis, and are applicable to various kinds of expression profiling data for any malignancy.

Keywords: Fuzzy neural network, Microarray, Gene expression profiling, Diffuse large B‐cell lymphoma, Prognosis

Full Text

The Full Text of this article is available as a PDF (143.7 KB).

REFERENCES

  • 1. ) Gatter , K. C. and Warnke , R. A.Diffuse large B‐cell lymphoma . In “ Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tisseus ,” ed. Jaffe E. S. , Harris N. L. , Stein H. and Vardimam J. M. , pp. 171 – 174 ( 2001. ). IARC Press; , Lyon , France . [Google Scholar]
  • 2. ) Engelhard , M. , Brittinger , G. , Huhn , D. , Gerhartz , H. H. , Meusers , P. , Siegert , W. , Thiel , E. , Wilmanns , W. , Aydemir , U. , Bierwolf , S. , Griesser , H. , Tiemann , M. and Lennert , K.Subclassification of diffuse large B‐cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor . Blood , 89 , 2291 – 2297 ( 1997. ). [PubMed] [Google Scholar]
  • 3. ) Wilson , W. H. , Teruya‐Feldstein , J. , Fest , T. , Harris , C. , Steinberg , S. M. , Jaffe , E. S. and Raffeld , M.Relationship of p53, bcl‐2, and tumor proliferation to clinical drug resistance in non‐Hodgkin's lymphomas . Blood , 89 , 601 – 609 ( 1997. ). [PubMed] [Google Scholar]
  • 4. ) Armitage , J. O. and Weisenburger , D. D.New approach to classifying non‐Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non‐Hodgkin's Lymphoma Classification Project . J. Clin. Oncol. , 16 , 2780 – 2795 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Yamaguchi , M. , Seto , M. , Okamoto , M. , Ichinohasama , R. , Nakamura , N. , Yoshino , T. , Suzumiya , J. , Murase , T. , Miura , I. , Akasaka , T. , Tamaru , J. , Suzuki , R. , Kagami , Y. , Hirano , M. , Morishima , Y. , Ueda , R. , Shiku , H. and Nakamura , S.De novo CD5+ diffuse large B‐cell lymphoma: a clinicopathologic study of 109 patients . Blood , 99 , 815 – 821 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Popat , U. , Przepiork , D. , Champlin , R. , Pugh , W. , Amin , K. , Mehra , R. , Rodriguez , J. , Giralt , S. , Romaguera , J. , Rodriguez , A. , Preti , A. , Andersson , B. , Khouri , I. , Claxton , D. , de Lima , M. , Donate , M. , Anderlini , P. , Gajewski , J. , Cabanillas , F. and van Besien , K.High‐dose chemotherapy for relapsed and refractory diffuse large B‐cell lymphoma: mediastinal localization predicts for a favorable outcome . J. Clin. Oncol. , 16 , 63 – 69 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Cerny , T. and Betticher , D.Role of high‐dose therapy in diffuse large B‐cell lymphoma . Ann. Oncol. , 11 ( Suppl. 3 ), 117 – 121 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) The International Non‐Hodgkin's Lymphoma Prognostic Factors Project . A predictive model for aggressive non‐ Hodgkin's lymphoma . N. Engl. J. Med. , 329 , 987 – 994 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Pomeroy , S. L. , Tamayo , P. , Gaasenbeek , M. , Sturla , L. M. , Angelo , M. , McLaughlin , M. E. , Kim , J. Y. , Goumnerova , L. C. , Black , P. M. , Lau , C. , Allen , J. C. , Zagzag , D. , Olson , J. M. , Curran , T. , Wetmore , C. , Biegel , J. A. , Poggio , T. , Mukherjee , S. , Rifkin , R. , Califano , A. , Stolovitzky , G. , Louis , D. N. , Mesirov , J. P. , Lander , E. S. and Golub , T. R.Prediction of central nervous system embryonal tumour outcome based on gene expression . Nature , 415 , 436 – 442 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Van't Veer , L. J. , Dai , H. , Van De Vijver , M. J. , He , Y. D. , Hart , A. A. , Mao , M. , Peterse , H. L. , Van Der Kooy , K. , Marton , M. J. , Witteveen , A. T. , Schreiber , G. J. , Kerkhoven , R. M. , Roberts , C. , Linsley , P. S. , Bernards , R. and Friend , S. H.Gene expression profiling predicts clinical outcome of breast cancer . Nature , 415 , 530 – 536 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Alizadeh , A. A. , Eisen , M. B. , Davis , R. E. , Ma , C. , Losses , I. S. , Rosenwald , A. , Boldrick , J. C. , Sabet , H. , Tran , T. , Yu , X. , Powell , J. I. , Yang , L. , Marti , G. E. , Moore , T. , Hudson , J. , Jr. , Lu , L. , Lewis , D. B. , Tibshirani , R. , Sherlock , G. , Chan , W. C. , Greiner , T. C. , Weisenburger , D. D. , Armitage , J. O. , Warnke , R. , Levy , R. , Wilson , W. , Greverss , M. R. , Byrd , J. C. , Bostein , D. , Brown , O. P. and Staudt , L. M.Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling . Nature , 403 , 503 – 511 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Shipp , M. A. , Ross , K. N. , Tamayo , P. , Weng , A. P. , Kutok , J. L. , Aguiar , R. C. , Gaasenbeek , M. , Angelo , M. , Reich , M. , Pinkus , G. S. , Ray , T. S. , Koval , M. A. , Last , K. W. , Norton , A. , Lister , T. A. , Mesirov , J. , Neuberg , D. S. , Lander , E. S. , Aster , J. C. and Golub , T. R.Diffuse large B‐cell lymphoma outcome prediction by gene‐expression profiling and supervised machine learning , Nat. Med. , 8 , 68 – 74 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Hanai , T. , Hibino , S. , Nagata , E. , Matsubara , M. , Fukagawa , K. , Shirataki , T. , Honda , H. and Kobayashi , T.Assessment of senile dementia of Alzheimer type using artificial neural networks . Jpn. J. Med. Electron. Biol. Eng. , 37 , 178 – 183 ( 1999. ) (in Japanese) . [Google Scholar]
  • 14. ) Noguchi , H. , Hanai , T. , Honda , H. , Harrison , L. C. and Kobayashi , T.Fuzzy neural network‐based prediction of the motif for MHC class II binding peptides . J. Biosci. Bioeng. , 92 , 227 – 231 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Sherlock , G. , Hernandez‐Boussard , T. , Kasarskis , A. , Binkley , G. , Matese , J. C. , Dwight , S. S. , Kaloper , M. , Weng , S. , Jin , H. , Ball , C. A. , Eisen , M. B. , Spellman , P. T. , Brown , P. O. , Botstein , D. and Cherry , J. M.The Stanford Microarray Database . Nucleic Acids Res. , 29 , 152 – 155 ( 2001. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Horikawa , S. , Furuhashi , T. , Uchikawa , Y. and Tagawa , T.A study on fuzzy modeling using fuzzy neural networks . Proc. Int. Fuzzy Eng. Symp. , 91 , 562 – 573 ( 1991. ). [Google Scholar]
  • 17. ) Noguchi , H. , Hanai , T. , Takahasi , W. , Ichii , T. , Tanikawa , M. , Masuoka , S. , Honda , H. and Kobayashi , T.Model construction for quality of beer and brewing process using FNN . J. Chem. Eng. Jpn. , 25 , 695 – 701 ( 1999. ). [Google Scholar]
  • 18. ) Goodnight , J.A tutorial on the SWEEP operator . Am. Stat. , 33 , 149 – 158 ( 1979. ). [Google Scholar]
  • 19. ) Khan , J. , Wei , J. S. , Ringner , M. , Saal , L. H. , Ladanyi , M. , Westermann , F. , Berthold , F. , Schwab , M. , Antonescu , C. R. , Peterson , C. and Meltzer , P. S.Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks . Nat. Med. , 1 , 673 – 679 ( 2001. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Mandel , M. , Rechavi , G. , Neumann , Y. , Biniaminov , M. , Rosenthal , E. , Toren , A. , Brok‐Simoni , F. , Ben‐Bassat , I. and Ramot , B.CD10+ cell population in the bone marrow of patients with advanced neuroblastoma . Med. Pediatr. Oncol. , 22 , 115 – 118 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Uckun , F. M. , Sather , H. , Gaynon , P. , Arthur , D. , Nachman , J. , Sensel , M. , Steinherz , P. , Hutchinson , R. , Trigg , M. and Reaman , G.Prognostic significance of the CD10(+) CD19(+) CD34(+) B‐progenitor immunophenotype in children with acute lymphoblastic leukaemia: a report from the Children's Cancer Group . Leuk. Lymphoma , 27 , 445 – 457 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Shipp , M. A. , Richardson , N. E. , Sayre , P. H. , Brown , N. R. , Masteller , E. L. , Clayton , L. K. , Ritz , J. and Reinherz , E. L.Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein . Proc. Natl. Acad. Sci. USA , 85 , 4819 – 4823 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Arber , D. A. and Weiss , L. M.CD10: a review . Appl. Immunohistochem. , 5 , 125 – 140 ( 1997. ). [Google Scholar]
  • 24. ) Harada , S. , Suzuki , R. , Uehira , K. , Yatabe , Y. , Kagami , Y. , Ogura , M. , Suzuki , H. , Oyama , A. , Kodera , Y. , Ueda , R. , Morishima , Y. , Nakamura , S. and Seto , M.Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5‐ with CD10+ groups may constitute clinically relevant subtypes . Leukemia , 13 , 1441 – 1447 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Iida , S. , Rao , P. H. , Butler , M. , Butler , M. , Corradini , P. , Boccadoro , M. , Klein , B. , Chaganti , R. S. and Dalla‐Favera , R.Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma . Nat. Genet. , 17 , 226 – 230 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Ichikawa , A. , Kinoshita , T. , Watanabe , T. , Kato , H. , Nagai , H. , Tsushita , K. , Saito , H. and Hotta , T.Mutations of the p53 gene as a prognostic factor in aggressive B‐cell lymphoma . N. Engl. J. Med. , 337 , 529 – 534 ( 1997. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES